AVI Biopharma, Inc.
3450 Monte Villa Parkway
Suite 101
Bothell,
WA 98021
United States - Map
Phone: 425-354-5038
Web Site: http://www.antivirals.com
| AVI BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products based on antisense and cancer immunotherapy technology. The companys products under various development stages comprise AVI-4658, a Phase I human clinical trial product to restore, prevent, or slow deterioration of muscle function; AVI-5038, a preclinical stage product to skip exon 50 and restore a range of associated mutations; AVI-5126, a Phase II clinical trial product for the treatment of cardiovascular restenosis; and AVI-6002 and AVI6003, which are in Phase I clinical trials to treat diseases caused by Dengue, Ebola, Marburg, and Junín viruses. It has strategic alliances with Chiron Corporation; Cook Group Incorporated; Ercole Biotech, Inc.; Eleos Inc.; Charleys Fund, Inc.; and the United States Department of Defense. The company was founded in 1980 and is based in Corvallis, Oregon. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Leslie Hudson Ph.D., 61
Chief Exec. Officer, Pres, Principal Operating Officer |
$
607.00K | N/A | Mr. J. David Boyle II, 55
Chief Financial Officer, Principal Accounting Officer, Sr. VP and Sec. |
$
166.00K | N/A | Dr. Patrick L. Iversen Ph.D., 53
Sr. VP of Strategic Alliances |
N/A
| N/A | Dr. Dwight D. Weller Ph.D., 58
Sr. VP of Chemistry & Manufacturing |
N/A
| N/A | Dr. Ryszard Kole Ph.D., 62
Sr. VP of Discovery Research |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
0.01 (0.67%) 
Profile
